Related Experiment Videos

Adrenergic sensitivity of cultured murine trisomy 16 cells

Developmental Pharmacology and Therapeutics
|January 1, 1985
PubMed

Insights

Murine trisomy 16 (Ts16) cells show reduced cyclic AMP (cAMP) response to adrenergic ligands, unlike Down

Area of Science:

  • Genetics
  • Pharmacology
  • Cell Biology

Background:

  • Murine trisomy 16 (Ts16) is a model for Down's syndrome (DS) due to gene homology with human chromosome 21.
  • Down's syndrome is characterized by altered sensitivity to adrenergic ligands.

Purpose of the Study:

  • To investigate the adrenergic ligand sensitivity in murine Ts16 fibroblasts and embryonic cells.
  • To determine if Ts16 is an appropriate model for studying altered adrenergic function in DS.

Main Methods:

  • Exposure of Ts16 cells to epinephrine and isoproterenol.
  • Measurement of cyclic AMP (cAMP) accumulation in response to adrenergic ligands and prostaglandin E1.

Main Results:

  • Ts16 cells exhibited a 2-4 fold reduction in cAMP accumulation upon stimulation with beta 1-adrenergic ligands (epinephrine, isoproterenol).
  • A similar reduction in cAMP was observed in response to prostaglandin E1, suggesting a broader adenylcyclase issue.
  • This response differs from that observed in cells from DS individuals.

Conclusions:

  • Murine Ts16 cells do not accurately model the specific adrenergic dysfunction seen in Down's syndrome.
  • The observed changes in Ts16 cells point to a generalized adenylcyclase alteration, not specific to DS-related adrenergic sensitivity.

Related Concept Videos